AI in Pharmacovigilance Market Size Regional Trends and Competitive Landscape
The AI-driven pharmacovigilance market is anticipated to grow at a compound annual growth rate (CAGR) of 12-15% from 2023 to 2030. This growth is fueled by the need to automate adverse event data processing, comply with increasingly stringent regulatory standards, harness advancements in AI analytics, reduce costs, and make use of real-world evidence. These factors […]
Continue Reading